Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CombiMatrix to Webcast Presentation at the Stephens 2005 Nanotechnology Investors Conference.


NEWPORT BEACH, Calif. -- Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG ACTG Acting
ACTG AIDS Clinical Trial Group
ACTG Actuating/Actuator
) announced today that Dr. Amit Kumar, President and Chief Executive Officer of CombiMatrix, will provide a company overview at the Stephens 2005 Nanotechnology Investors Conference to be held April 5-6, 2005 at The Ritz-Carlton Hotel in Pasadena, California.

A live transmission of the presentation will take place at 3:00 PM (PST PST Paroxysmal supraventricular tachycardia, see there ) / 6:00 PM (EST EST electroshock therapy.

EST
abbr.
electroshock therapy
) on Tuesday, April 5, 2005. An archived webcast will be available for 90 days. To access the live webcast or archived presentation, please go to www.combimatrix.com/news_events.htm.

ABOUT ACACIA RESEARCH CORPORATION

Acacia Research Corporation comprises two operating groups: Acacia Technologies Group and CombiMatrix Group.

The CombiMatrix group is developing a platform technology to rapidly produce customizable arrays, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. CombiMatrix provides DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 arrays to researchers under the CustomArray(TM) brand. The CombiMatrix's group's technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology.

The Acacia Technologies group develops, acquires, and licenses patented technologies. Acacia controls 29 patent portfolios, which include 126 U.S. patents, and certain foreign counterparts, covering technologies used in a wide variety of industries including audio/video enhancement & synchronization, broadcast data retrieval, computer memory cache coherency, credit card fraud Credit card fraud is a wide-ranging term for theft and fraud committed using a credit card or any similar payment mechanism as a fraudulent source of funds in a transaction. The purpose may be to obtain goods without paying, or to obtain unauthorized funds from an account.  protection, database management, data encryption & product activation, digital media transmission (DMT See DSL. (R)), digital video production, dynamic manufacturing modeling, enhanced Internet navigation, image resolution enhancement, interactive data sharing, interactive television, Internet access redirection, interstitial Internet advertising, microprocessor enhancement, multi-dimensional bar codes, network data storage, resource scheduling, rotational video imaging and spreadsheet automation.

Acacia Research-Acacia Technologies (Nasdaq:ACTG) and Acacia Research-CombiMatrix (Nasdaq:CBMX) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups.

Information about the Acacia Technologies group and the CombiMatrix group is available at www.acaciaresearch.com.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
, recent and forthcoming Quarterly Reports on Form 10-Q Form 10-Q

See 10-Q.
, recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 29, 2005
Words:512
Previous Article:Bain Capital Ventures Invests in Kiva Systems; Firm Leads $6.5 Million Series B Funding Round to Drive Commercialization of Company's Mobile...
Next Article:Acme United Corporation Board Approves Cash Dividend.



Related Articles
Tegal Corporation Management to Present at Stephens Inc. Nanotechnology Investors Conference.
Kopin to Present at the 2005 Stephens Nanotechnology Investors Conference.
Biophan to Present at Stephens Inc. 2005 Nanotechnology Investors Conference April 5 - 6 in California; CEO Michael Weiner to Outline Company's...
Accelrys to Present at the Annual Stephens Nanotechnology Conference.
Symyx Technologies to Present at Stephens Investors Conference.
NaturalNano President Michael Riedlinger Unveils Proprietary Applications for 'Halloysite Nanotubes' at Stephens Inc. 2005 Nanotechnology Investors...
CombiMatrix to Hold Conference Call to Discuss Business Strategy for CombiMatrix Molecular Diagnostics.
CombiMatrix to Webcast Presentation at the Thomas Weisel Partners Healthcare Tailwinds Conference 2005.
CombiMatrix to Webcast Presentation at Rodman and Renshaw Techvest 7th Annual Healthcare Conference.
CombiMatrix to Webcast Presentation at Invest Northwest(TM) 2006 Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles